marcus evans north america conferences

LIVE Virtual Training - Strategies in Pharmacovigilance & Risk Management

Build a Comprehensive PV Program to Predict Drug Safety & Mitigate Risk Throughout the Product Lifecycle

26-28 Apr 2022
10 AM - 1:30 PM CST, United States of America


Why You Should Attend

LIVE Virtual Training - Strategies in Pharmacovigilance & Risk Management

Heightened demand for new drugs has increased the need for streamlined pharmacovigilance processes within clinical trials, research and development, and overall reporting when it comes to drug safety. PV professionals need to increase their skill set while mentoring and leading the drug safety teams that keep patients safe across the globe.

This trainer-led, live virtual session will be offered in a 3x3 format (3 hours of e-learning over 3 days [two 90-minute sessions/per day] for a total of 9 hours.

Key Topics

  • Pharmacovigilance Status Evaluation
  • Communicate Health Data and Findings
  • US vs EU Regulations and Standards
  • Benefit-Risk Management
  • The Future of Pharmacovigilance

    • Previous Attendees Include

    Acorda Therapeutics
    Agios Pharmaceuticals
    Amicus Therapeutics
    Astellas Pharma
    AstraZeneca
    Baxter BioScience
    Gilead
    Gilead Sciences Inc
    Glenmark Generics Inc USA
    Jazz Pharmaceuticals
    Macrogenics
    Merck
    Mirari Therapeutics Inc
    Neurocrine Biosciences Inc
    Sagent Pharmaceuticals Inc
    Septodont-Vovocol Pharamaceutical
    Torrent Pharma Inc
    United Therapeutics


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.






    Practical Insights From

    John Price

    He is a physician trained in Clinical Pharmacology with more than 26 years of experience in drug development, risk-benefit evaluation pre- and post-approval, pharmacovigilance and regulatory affairs gained during senior leadership positions in large Pharma, a rare diseases Biotech, start-ups, Consumer Health, and a leading European Regulatory Agency.

    Click Here For Full Agenda

    Voice of Our Customers
    • “The content was tailored to everyone’s needs. It was great learning more about REMS, statistical analysis for signals, and overall tips and tricks in PV.” - Gilead
    • “Good understanding of mandatory PV regulation in EU/US.” - Glenmark Pharmaceuticals
    • “...the course was tailored to the specific needs of the group but at the same time, provided a great overview training on PV and Risk Management…The case studies were particularly helpful.” - United Therapeutics
    • “Engaging and great examples provided.” - Gilead
    Join the Discussion





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Emily Jones

    marcusevans, The NBC Tower
    455 N. Cityfront Plaza Dr.
    Chicago, IL 60611

    Telephone:     312.540.3000 x6714
    Fax: 312.894.6304
    Email: emilyj@marcusevansch.com